David Young - Pres. Research & Development, Director at Processa Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Pres. Research & Development, Director
Issuer Symbol
PCSA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Young since 11 Feb 2025

Holdings reported by David Young for Processa Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 0 $43,015 $1.71 01 Jan 2026 Direct Common Stock
Common Stock 8,752 $1,050 $0.1200 01 Jan 2026 Direct
Common Stock 1,242 $149 $0.1200 01 Jan 2026 By Young-Plaisance Revocable Trust
Common Stock 742 $89 $0.1200 01 Jan 2026 By CorLyst, LLC
Common Stock 432 $51 $0.1200 01 Jan 2026 By Family Entities
Stock Options (Right to Buy) 333,000 01 Oct 2025 Direct Common Stock
Warrants 62,250 29 Jan 2025 Direct Common Stock

Transactions reported by David Young for Processa Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.